Back to Browse Journals » Clinical Ophthalmology » Volume 2 » Issue 2

Autoimmune destruction of pericytes as the cause of diabetic retinopathy

Authors Duncan D Adams

Published Date June 2008 Volume 2008:2(2) Pages 295—298

DOI http://dx.doi.org/10.2147/OPTH.S2629

Published 30 June 2008

Duncan D Adams

Faculty of Medicine, University of Otago, Dunedin, New Zealand

Abstract: In diabetic retinopathy, collapse of the retinal vasculature is associated with loss of the pericytes. These are contractile cells that together with endothelial cells form the terminal arterioles of the retina. The cause of the loss of pericytes is not known. Recently, it has been discovered that type 1 diabetes is caused by forbidden clones of cytotoxic T lymphocytes, which destroy the insulin-making cells with exquisite specificity. In the light of this, I postulate that an antigenically-related forbidden clone of cytotoxic T lymphocytes selectively destroys the pericytes and that this is the cause of the vascular collapse of diabetic retinopathy. If this is so, the therapeutic implications are immense, involving a switch from ineffectual tight glycemic control to immunotherapy. This is already used as immunosuppression to prevent organ transplant rejection, and as the immune ablation and autologous bone marrow cell reconstitution that has saved the lives of patients with lethally-severe scleroderma. Once the pericyte surface auto-antigen for the T lymphocytes has been isolated, selective destruction of the pathogenic T lymphocytes would be possible by manufacture and use of cytotoxic auto-antigen complexes, which arrests progression of the retinopathy.

Keywords: pericytes, diabetic retinopathy, autoimmunity, T cell forbidden clones, immunotherapy

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Complication rate of posterior capsule rupture with vitreous loss during phacoemulsification at a Hawaiian cataract surgical center: a clinical audit

Chen M, LaMattina KC, Patrianakos T, Dwarakanathan S

Clinical Ophthalmology 2014, 8:375-378

Published Date: 5 February 2014

Efficacy of reduced-fluence photodynamic therapy for serous retinal pigment epithelial detachment with choroidal hyperpermeability

Shibata A, Ohkuma Y, Hayashi T, Tsuneoka H

Clinical Ophthalmology 2013, 7:2123-2126

Published Date: 30 October 2013

New dilemmas in small-cell lung cancer TNM clinical staging

Zarogoulidis K, Latsios D, Porpodis K, Zarogoulidis P, Darwiche K, Antoniou N, Hohenforst-Schmidt W, Eleftheriadou E, Boutsikou E, Kontakiotis T

OncoTargets and Therapy 2013, 6:539-547

Published Date: 16 May 2013

Reduced prefrontal cortex activation using the Trail Making Test in schizophrenia

Fujiki R, Morita K, Sato M, Kamada Y, Kato Y, Inoue M, Shoji Y, Uchimura N

Neuropsychiatric Disease and Treatment 2013, 9:675-685

Published Date: 16 May 2013

Completeness of prostate cancer staging in the Danish Cancer Registry, 2004–2009

Nguyen-Nielsen M, Frøslev T, Friis S, Borre M, Harving N, Søgaard M

Clinical Epidemiology 2012, 4:17-23

Published Date: 17 August 2012

Evidence to support the use of vildagliptin monotherapy in the treatment of type 2 diabetes mellitus

Dejager S, Schweizer A, Foley JE

Vascular Health and Risk Management 2012, 8:339-348

Published Date: 18 May 2012

Luminescent single-walled carbon nanotube-sensitized europium nanoprobes for cellular imaging

Avti PK, Sitharaman B

International Journal of Nanomedicine 2012, 7:1953-1964

Published Date: 17 April 2012

Anterior segment granuloma and optic nerve involvement as the presenting signs of systemic sarcoidosis

Marilita M Moschos, Yan Guex-Crosier

Clinical Ophthalmology 2008, 2:951-953

Published Date: 20 November 2008